{"disease":{"id":"hypercholesterolemia-and-hyperlipidemia","name":"hypercholesterolemia and hyperlipidemia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07421284","title":"A Study to Evaluate the Safety, Efficacy of SYH2053 in Chinese Participants With Non-familial Hypercholesterolemia and Mixed Hyperlipidemia on a Background of Lipid-lowering Therapy","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":900,"lead_sponsor_name":"CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.","has_results":false},{"nct_id":"NCT07421297","title":"A Study to Evaluate the Safety, Efficacy of SYH2053 as Monotherapy in Chinese Participants With Non-familial Hypercholesterolemia or Mixed Hyperlipidemia","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":760,"lead_sponsor_name":"CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.","has_results":false},{"nct_id":"NCT07238257","title":"Effectiveness of Digital Health Intervention on Community Health Care in Middle-aged and Older Population in Taiwan","phase":"NA","overall_status":"COMPLETED","enrollment_count":199,"lead_sponsor_name":"Chang Gung Memorial Hospital","has_results":false},{"nct_id":"NCT07473960","title":"IBI306 Monotherapy in Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":198,"lead_sponsor_name":"Innovent Biologics (Suzhou) Co. Ltd.","has_results":false},{"nct_id":"NCT05370950","title":"Study of Bioavailability, Pharmacodynamics and Safety of SHR-1209 Administered by Single Subcutaneous Injection at Different Sites in Healthy Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":159,"lead_sponsor_name":"Jiangsu HengRui Medicine Co., Ltd.","has_results":false},{"nct_id":"NCT07421232","title":"A Study to Evaluate the Safety, Efficacy of SYH2053 in Chinese Participants With Non-familial Hypercholesterolemia and Mixed Hyperlipidemia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":156,"lead_sponsor_name":"CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.","has_results":false},{"nct_id":"NCT06894004","title":"Mechanism of Ketogenic Diet-Induced Hypercholesterolemia","phase":"NA","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Washington University School of Medicine","has_results":false}],"total":7},"guidelines":[],"source":"Drug Landscape verified database"}